Mayo Clinic has one of the largest and most experienced practices in the United States,
with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work
together to ensure quality care and successful recovery.
Mayo Clinic doctors and scientists created one of the largest patient and tissue registries for pancreatic cancer in the United States. This registry is an important tool for cancer research.
Mayo Clinic doctors and scientists are dedicated to improving the care of people with pancreatic cancer.
Mayo Clinic is one of the few medical centers in the U.S. recognized as a Specialized Program of Research Excellence (SPORE) for pancreatic cancer research, funded by the National Cancer Institute (NCI). And at Mayo Clinic's Gastrointestinal Cancer Program, researchers study new diagnostic tools, treatments and approaches to prevention of pancreatic cancer. They are advancing scientific knowledge of cancers affecting the intestinal tract and improving the quality of life of people affected by these diseases.
Mayo Clinic is also active in a large NCI-funded multisite study, conducted by the Pancreatic Cancer Genetic Epidemiology (PACGENE) Consortium, looking at the role heredity plays in pancreatic cancer. To aid this research, Mayo Clinic has created one of the largest patient and tissue registries for pancreatic cancer in the United States.
Mayo Clinic doctor Michael B. Wallace, M.D., discusses methods of screening people at high risk of pancreatic cancer in order to diagnose the condition earlier.